What does cbd do to our endocannabinoid system and body ?
CBD (cannabidiol) interacts with the endocannabinoid system (ECS) in a complex manner, albeit different from other cannabinoids like THC. While CBD does not directly bind to cannabinoid receptors like CB1 and CB2, it exerts its effects on the ECS and the rest of our body through various indirect mechanisms.
Functions of CBD on our Endocannabinoid system
Modulating Receptor Activity: CBD acts as a modulator of CB1 and CB2 receptors. It is considered an allosteric modulator, meaning it influences the receptors’ activity without directly binding to them. CBD can enhance or inhibit the binding of other compounds, including endocannabinoids like anandamide, to these receptors. By doing so, CBD can alter the signaling and response of the ECS.
Inhibiting Enzyme Activity: CBD inhibits the activity of enzymes responsible for breaking down endocannabinoids like anandamide. By blocking the action of enzymes such as fatty acid amide hydrolase (FAAH), CBD helps increase the levels of endocannabinoids in the body. This allows endocannabinoids to exert their effects for longer periods, potentially contributing to the maintenance of balance within the ECS.
Functions of CBD outside of our endocannabinoid system
Interacting with Non-Cannabinoid Receptors: CBD interacts with various non-cannabinoid receptors in the body, expanding its influence beyond the ECS. For example, CBD interacts with serotonin receptors (5-HT1A), which play a role in mood regulation and anxiety. By interacting with these receptors, CBD may contribute to its potential anxiolytic and antidepressant effects.
Influencing TRPV1 Receptors: CBD also interacts with TRPV1 (transient receptor potential vanilloid 1) receptors, which are involved in the perception of pain, inflammation, and body temperature. There has been evidence that CBD can desensitize these receptors.
Modulating Adenosine Receptors: CBD has been found to interact with adenosine receptors, which are involved in regulating sleep, pain perception, and inflammation. Studies have shown that CBD has the potential to enhance the receptiveness of these receptors.
It’s important to note that while CBD has various interactions with the ECS, its effects are often considered indirect and modulatory rather than directly activating cannabinoid receptors like THC. This distinction is why CBD does not produce the psychoactive effects commonly associated with THC.